Healwell AI Inc (AIDX.TO)
2.33
-0.06
(-2.51%)
CAD |
TSX |
Jun 25, 16:00
Healwell AI Enterprise Value: 397.77M for June 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 24, 2024 | 397.77M |
June 21, 2024 | 381.88M |
June 20, 2024 | 386.65M |
June 19, 2024 | 440.64M |
June 18, 2024 | 435.88M |
June 17, 2024 | 458.11M |
June 14, 2024 | 469.23M |
June 13, 2024 | 450.17M |
June 12, 2024 | 500.99M |
June 11, 2024 | 443.82M |
June 10, 2024 | 488.29M |
June 07, 2024 | 381.88M |
June 06, 2024 | 346.95M |
June 05, 2024 | 342.18M |
June 04, 2024 | 340.59M |
June 03, 2024 | 318.36M |
May 31, 2024 | 316.77M |
May 30, 2024 | 335.83M |
May 29, 2024 | 316.77M |
May 28, 2024 | 307.24M |
May 27, 2024 | 334.24M |
May 24, 2024 | 291.36M |
May 23, 2024 | 281.83M |
May 22, 2024 | 280.25M |
May 21, 2024 | 260.12M |
Date | Value |
---|---|
May 17, 2024 | 255.80M |
May 16, 2024 | 234.20M |
May 15, 2024 | 234.20M |
May 14, 2024 | 234.20M |
May 13, 2024 | 222.68M |
May 10, 2024 | 224.12M |
May 09, 2024 | 225.56M |
May 08, 2024 | 232.76M |
May 07, 2024 | 229.88M |
May 06, 2024 | 241.40M |
May 03, 2024 | 234.20M |
May 02, 2024 | 247.16M |
May 01, 2024 | 234.20M |
April 30, 2024 | 237.08M |
April 29, 2024 | 234.20M |
April 26, 2024 | 239.96M |
April 25, 2024 | 241.40M |
April 24, 2024 | 232.76M |
April 23, 2024 | 244.28M |
April 22, 2024 | 244.28M |
April 19, 2024 | 235.64M |
April 18, 2024 | 248.60M |
April 17, 2024 | 225.56M |
April 16, 2024 | 254.36M |
April 15, 2024 | 291.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.36M
Minimum
May 05 2023
500.99M
Maximum
Jun 12 2024
132.31M
Average
107.66M
Median
Feb 01 2022
Enterprise Value Benchmarks
WELL Health Technologies Corp | 1.492B |
Biocure Technology Inc | 1.450M |
Core One Labs Inc | 5.747M |
Nova Mentis Life Science Corp | 3.005M |
Nanosphere Health Sciences Inc | 0.5028M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -5.927M |
Revenue (Quarterly) | 4.579M |
Total Expenses (Quarterly) | 10.02M |
EPS Diluted (Quarterly) | -0.06 |
Gross Profit Margin (Quarterly) | 52.17% |
Profit Margin (Quarterly) | -129.4% |
Earnings Yield | -20.17% |
Normalized Earnings Yield | -13.90 |